A Curated Platform of Equity & Options Market Intelligence
Select Page

EPZM

Search by
TICKER SYMBOL

EPZM

Sector: Manufacturing
Industry: Pharmaceutical Products

(%)

Volume:

52 week range:

-

Market Cap:

245.475M

Company Description:

Epizyme, Inc., a commercial-stage biopharmaceutical company, discovers, develops, and commercializes novel epigenetic medicines. The company offers Tazemetostat for the treatment of metastatic or locally advanced epithelioid sarcoma for adults and pediatric patients. It also develops R-CHOP in front-line patients with high risk diffuse large B-cell lymphoma.